Schedule 13G ownership disclosure
LIXTE BIOTECHNOLOGY HLDGS IN
Common Stock · CUSIP: 539319301
Event date: 2026-09-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- North York Ltd
Shares: 1,838,273.00 · Class: 9.8%
- Ashwood Leon Forbes
Shares: 1,838,273.00 · Class: 9.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001753926-26-002019
- Form type
- SCHEDULE 13G
- Filer
- North York Ltd
- CIK
- CIK 2093582
- Filed
- Oct 28, 2026
- Reporting period
- Sep 03, 2026
- Description
- Schedule 13G beneficial ownership